Code Pharma has reported encouraging eight-week results for its HIV drug, Gammora, suggesting a potential to eradicate the virus at the cellular level. As published on BusinessWire, the preliminary findings were shared at the HIV
Code Pharma has reported promising results from an eight-week clinical study of Gammora, a novel drug aimed at targeting HIV. The findings, shared at the 2024 HIV Drug Therapy Conference in Glasgow, suggest Gammora could
As published by ‘Dutch News’, Code Pharma has reported positive results from an eight-week study of its HIV treatment candidate, Gammora, suggesting it may provide a cellular-level approach to curing HIV. The preliminary findings were
Code Pharma, a Dutch pharmaceutical company, will showcase its innovative HIV drug, GAMMORA, at two global conferences in late 2024. First, in November at the HIV Drug Therapy Conference in Glasgow, early clinical trial results